Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Personality Characteristics and Compliance With Antiglaucoma Medication (GDC)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2007 by Yonsei University.
Recruitment status was  Recruiting
Information provided by:
Yonsei University Identifier:
First received: May 31, 2007
Last updated: NA
Last verified: May 2007
History: No changes posted
Personality traits may influence to the drug compliance in glaucoma patients.


Study Type: Observational
Study Design: Time Perspective: Cross-Sectional
Time Perspective: Prospective
Official Title: Personality Characteristics and Compliance With Antiglaucoma Medication

Resource links provided by NLM:

Further study details as provided by Yonsei University:

Estimated Enrollment: 150
Study Start Date: May 2007
Estimated Study Completion Date: October 2007
Detailed Description:
In chronic diseases, especially asymptomatic at early stage, drug compliance has been reported as an important factor to control them. And personality traits are associated with the drug compliance. However, there was few study to consider this relationship. We want to find the association the personality characteristics and drug compliance in glaucoma patients.

Ages Eligible for Study:   20 Years to 80 Years   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Chronic glaucoma
  • Topical anti-glaucoma medications

Exclusion Criteria:

  • Oral glaucoma medications
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00481494

Contact: Chan Yun Kim, MD, PhD 82-2-2228-3580

Korea, Republic of
Severance Hospital, Yonsei University College of Medicine Recruiting
Seoul, Korea, Republic of, 120-752
Contact: Chan Yun Kim, MD, PhD    82-2-2228-3580   
Sponsors and Collaborators
Yonsei University
Study Chair: Chan Yun Kim, MD, PhD Department of Ophthalmology, Yonsei University College of Medicine
  More Information Identifier: NCT00481494     History of Changes
Other Study ID Numbers: 4-2007-0092 
Study First Received: May 31, 2007
Last Updated: May 31, 2007
Health Authority: Republic of Korea: Institutional Review Board

Keywords provided by Yonsei University:
Drug compliance

Additional relevant MeSH terms:
Ocular Hypertension
Eye Diseases processed this record on October 27, 2016